compounded semaglutide update for Women Semaglutide | GoodGirlRx
Description
Per publicly available announcements, the FDA issued more than 50 warning letters to GLP-1 compounders and manufacturers in September 2025, followed by 30 additional warning letters to telehealth firms in early 2026, targeting false or misleading marketing claims about compounded GLP-1 products
Prevention of diabetes and cardiovascular disease in obesity
Breakthrough Therapy designation, if granted, would facilitate more frequent FDA interactions and potentially accelerate the review
The sensation can persist for hours or even the entire day following an injection
The needle is tiny, and most people report only minor discomfort when injecting
It behaves like sugar in the kitchen and on the palate, but not in the bodywhere it may actually improve blood sugar control and support weight loss
